T-cell antigen receptor
Structure and function of the T cell antigen receptor
... This has been further supported by more recent experiments in which a heterologous receptor that activates the inositol phospholipid pathway, the human muscarinic receptor subtype 1, whe[r] ...
9
Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas
... productive rearrangements could be ascribed to V delta 1J delta 1 joining in 3 cases and VJ delta 1 joining in 2 cases according to the combined pattern of DNA hybridization with the appropriate probes and of cell ...
8
Stimulation of CD5 enhances signal transduction by the T cell antigen receptor
... mediated production of inositol phosphates to be sustained at a brisk rate for greater than 20 min and augments the initial CD3-mediated increase in inositol trisphosphate and release of intracellular Ca2+. Thus, ...
6
Molecular characterisation of the T-cell receptors expressed in rheumatoid arthritis patients
... Structure of T cell antigen receptor fi chain in synovial fluid cells from patients with rheumatoid arthritis.. Elevation of a 10 T cell subset in peripheral blood and synovial fluid of [r] ...
304
Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.
... Although it remains possible that stimulation of the T-cell antigen receptor may indirectly activate T-cell gene products, for example, tumor necrosis factor alpha, which activate the HI[r] ...
5
Bias toward use of a specific T cell receptor beta chain variable region in a subgroup of individuals with sarcoidosis
... of T cell antigen receptor beta variable (V) regions may be manifested in T lymphocytes that accumulate in nonmalignant, T cell- mediated human disorders, a V beta ...
10
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
... adoptive cell immunotherapy, which uses chimeric antigen receptor-modified T cells (CAR-T) or genetically modified NK cells, has been shown to be a promising strategy for the treatment ...
21
<p>Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy</p>
... Abstract: Chimeric antigen receptor (CAR)-modi fi ed T cell therapy is increasingly adminis- tered for hematological malignancies. Cytokine release syndrome (CRS) is a common and severe ...
6
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
... most neurologic toxicity is reversible and can recover spontaneously without further treatment. At present, CAR-T-cell-therapy-associated toxicity 10-point neuro- logical assessment score is recommended to ...
12
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
... B cell lymphoma and leukemia therapy [1, ...chimeric antigen receptor (CAR) – engineered T cells target- ing CD19 has opened a new era with “living drugs” for can- cer immunotherapy ...
5
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
... optimal T-cell subset as the material for preparing CAR-T can enhance the effect of the ...endogenous T cells, after receiving the pMHC signal, naive T cells differentiate into T ...
12
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (FR3) in Thai malignant lymphoma by High Resolution Melting curve analysis
... of antigen receptor gene rearrangement including T cell receptor (TCR) and immunoglobulin heavy chain (IgH) by polymerase chain reaction followed by heteroduplex has currently become ...
9
Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases
... resting T cells, CD45 may counteract the neg- ative regulation of Csk by dephosphorylating the nega- tive regulatory, and to a lesser extent the autocatalytic, tyrosine in SFKs, providing a pool of ...
7
Cancer biomarkers for targeted therapy
... bispecific T cell engagers, and antibody-drug ...B cell maturation antigen, and CD138 are targets for cancer immunotherapeutic agents, including the chimeric antigen receptor - ...
7
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
... tumor-specific T-cells into patients, a so called “adoptive cell transfer”, or ACT, ...allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted ...
17
Molecular analysis of the helper T cell response in murine interstitial nephritis T cells recognizing an immunodominant epitope use multiple T cell receptor V beta genes with similarities across CDR3
... target antigen, 3M-1. Evaluation of the T cell receptor (TCR) V beta repertoire used by these autoreactive T cells reveals the use of several V beta genes, but with some preference for ...
10
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
... tumor antigen-specific T cells due to clonal deletion; 2) poor activation of innate immune cells and accumulation of tolerigenic antigen-presenting cells in the tumor microenvironment; 3) formation ...
9
Antigen-Driven T-Cell Selection in Patients with Cervical Cancer as Evidenced by T-Cell Receptor Analysis and Recognition of Autologous Tumor
... one T-cell population could be potentially “masked” if the same TCR VA or VB family shows a polyclonal composition ...target cell line Daudi or the NK-sensitive target cell line K562 served as ...
12
MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
... Then, T cells were collected from a healthy donor, activated by CD3/ CD28, expanded by IL-2 and transfected by mCAR lenti- virus to produce mCART, which showed high transfec- tion efficiencies and appropriate ...
18
B cell antigen receptor-induced activation of an IRAK4-dependent signaling pathway revealed by a MALT1-IRAK4 double knockout mouse model
... IL-1 receptor and TLR families ...factor receptor (TNFR) familiy member trans- membrane activator and calcium modulator and cyclo- philin ligand interactor (TACI) to control T cell- ...
9